• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于宫颈样本中全面人乳头瘤病毒基因分型的病毒宏基因组捕获测序

Virome capture sequencing for comprehensive HPV genotyping in cervical samples.

作者信息

Sasivimolrattana Thanayod, Liewchalermwong Sasiprapa, Chantratita Wasun, Sensorn Insee, Chaiwongkot Arkom, Bhattarakosol Parvapan

机构信息

Department of Microbiology, Faculty of Public Health, Mahidol University, Bangkok, Thailand.

Center of Excellence in Applied Medical Virology, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

出版信息

Sci Prog. 2025 Apr-Jun;108(2):368504251334515. doi: 10.1177/00368504251334515. Epub 2025 Apr 15.

DOI:10.1177/00368504251334515
PMID:40232222
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12035491/
Abstract

ObjectiveThis study aims to explore HPV genotyping in the cervical specimen using VirCapSeq by comparing the results with the reverse blot hybridization assay (REBA).MethodsA secondary cross-sectional data of HPV genotypes in 35 cervical specimens was obtained from VirCapSeq and REBA methods. The .FASTQ files were downloaded from the NCBI Sequence Read Archive (SRA) (accession number PRJNA766412) and HPV genotyping was bioinformatically analyzed by mapping the sequences to the PaVE database. HPV genotypes detected by REBA and NGS were compared. All specimens were stratified by histology into cervical intraepithelial neoplasia grades 1 (CIN1) and 2/3 (CIN2/3).ResultsNGS via VirCapSeq detected HPV DNA in 100% of the samples, whereas the REBA (hybridization-based) assay diagnosed HPV DNA in 85.71%. While the limitation of the conventional methods for HPV genotyping is the use of primers or probes, NGS detected a broader range. The results showed that mixed infections were detected in all samples by NGS, with HPV16 and HPV52 being the most abundant genotypes.ConclusionsHPV genome abundance, coverage, and diversity were associated with detection discrepancies between the methods, highlighting the enhanced sensitivity and diagnostic capabilities of NGS. These findings underscore the potential of NGS technologies for comprehensive HPV genotyping, advancing cervical cancer screening, and epidemiological studies. Future research should address cost barriers and expand cohort sizes to validate these findings.

摘要

目的

本研究旨在通过将结果与反向杂交检测法(REBA)进行比较,探索使用VirCapSeq对宫颈标本进行HPV基因分型。

方法

从VirCapSeq和REBA方法中获取35份宫颈标本中HPV基因型的二次横断面数据。.FASTQ文件从NCBI序列读取存档(SRA)(登录号PRJNA766412)下载,并通过将序列映射到PaVE数据库对HPV基因分型进行生物信息学分析。比较REBA和NGS检测到的HPV基因型。所有标本按组织学分层为宫颈上皮内瘤变1级(CIN1)和2/3级(CIN2/3)。

结果

通过VirCapSeq进行的NGS在100%的样本中检测到HPV DNA,而REBA(基于杂交)检测法诊断出HPV DNA的样本为85.71%。虽然传统HPV基因分型方法的局限性在于使用引物或探针,但NGS检测范围更广。结果显示,NGS在所有样本中均检测到混合感染,其中HPV16和HPV52是最常见的基因型。

结论

HPV基因组丰度、覆盖率和多样性与不同方法之间的检测差异相关,突出了NGS更高的灵敏度和诊断能力。这些发现强调了NGS技术在全面HPV基因分型、推进宫颈癌筛查和流行病学研究方面的潜力。未来的研究应解决成本障碍并扩大队列规模以验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/23df6418180f/10.1177_00368504251334515-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/285c2468bbef/10.1177_00368504251334515-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/4a1f8f922113/10.1177_00368504251334515-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/e7bfec20ce31/10.1177_00368504251334515-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/23df6418180f/10.1177_00368504251334515-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/285c2468bbef/10.1177_00368504251334515-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/4a1f8f922113/10.1177_00368504251334515-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/e7bfec20ce31/10.1177_00368504251334515-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6cc/12035491/23df6418180f/10.1177_00368504251334515-fig4.jpg

相似文献

1
Virome capture sequencing for comprehensive HPV genotyping in cervical samples.用于宫颈样本中全面人乳头瘤病毒基因分型的病毒宏基因组捕获测序
Sci Prog. 2025 Apr-Jun;108(2):368504251334515. doi: 10.1177/00368504251334515. Epub 2025 Apr 15.
2
Targeted next generation sequencing panel for HPV genotyping in cervical cancer.用于宫颈癌 HPV 基因分型的靶向下一代测序 panel。
Exp Mol Pathol. 2021 Feb;118:104568. doi: 10.1016/j.yexmp.2020.104568. Epub 2020 Nov 7.
3
High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.中国农村人群高危型人乳头瘤病毒基因型分布及其与宫颈癌和癌前病变的关系
J Gynecol Oncol. 2017 Jul;28(4):e30. doi: 10.3802/jgo.2017.28.e30.
4
Human papillomavirus genotyping by Linear Array and Next-Generation Sequencing in cervical samples from Western Mexico.墨西哥西部宫颈样本中通过线性阵列和下一代测序进行人乳头瘤病毒基因分型
Virol J. 2015 Oct 6;12:161. doi: 10.1186/s12985-015-0391-4.
5
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.采用 VALGENT 框架对 INNO-LiPA HPV Genotyping II assay 的临床评估。
Int J Mol Sci. 2018 Sep 11;19(9):2704. doi: 10.3390/ijms19092704.
6
CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology.HPV DNA 基因芯片分型检测与 Cobas 4800 HPV 检测和细胞学比较在 CIN2+中的检测。
Virol J. 2019 Jul 23;16(1):92. doi: 10.1186/s12985-019-1197-6.
7
Comparative analysis of cervical cytology and human papillomavirus genotyping by three different methods in a routine diagnostic setting.在常规诊断环境中,通过三种不同方法对宫颈细胞学和人乳头瘤病毒基因分型进行比较分析。
Eur J Cancer Prev. 2015 Sep;24(5):447-53. doi: 10.1097/CEJ.0000000000000100.
8
Comparison of the hybrid capture II assay with the human papillomavirus DNA chip test for the detection of high-grade cervical lesions.杂交捕获II检测法与人乳头瘤病毒DNA芯片检测法在检测高级别宫颈病变中的比较。
Int J Gynecol Cancer. 2009 Jul;19(5):924-8. doi: 10.1111/IGC.0b013e3181a832a2.
9
REBA HPV-ID® for efficient genotyping of human papillomavirus in clinical samples from Korean patients.REBA HPV-ID® 用于对韩国患者临床样本中的人乳头瘤病毒进行高效基因分型。
J Med Virol. 2012 Aug;84(8):1248-53. doi: 10.1002/jmv.23334.
10
The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.人乳头瘤病毒 16/18 型基因分型杂交捕获法在宫颈癌筛查初筛中检测人乳头瘤病毒 DNA 的性能:10669 例中国女性的横断面研究。
Clin Microbiol Infect. 2018 Dec;24(12):1322-1327. doi: 10.1016/j.cmi.2018.02.027. Epub 2018 Mar 5.

本文引用的文献

1
High-Risk Human Papillomavirus Detection via Cobas 4800 and REBA HPV-ID Assays.基于 Cobas 4800 系统和 REBA HPV-ID 检测试剂盒的高危型人乳头瘤病毒检测。
Viruses. 2022 Dec 3;14(12):2713. doi: 10.3390/v14122713.
2
Human Papillomavirus: Challenges and Opportunities for the Control of Cervical Cancer.人乳头瘤病毒:控制宫颈癌面临的挑战与机遇
Arch Med Res. 2022 Dec;53(8):753-769. doi: 10.1016/j.arcmed.2022.11.009. Epub 2022 Nov 30.
3
Cervical Microbiome in Women Infected with HPV16 and High-Risk HPVs.HPV16 感染及高危型 HPV 感染妇女的宫颈微生物组
Int J Environ Res Public Health. 2022 Nov 9;19(22):14716. doi: 10.3390/ijerph192214716.
4
Human Virome in Cervix Controlled by the Domination of Human Papillomavirus.人乳头瘤病毒主导的宫颈人病毒组。
Viruses. 2022 Sep 17;14(9):2066. doi: 10.3390/v14092066.
5
Using HPV-meta for human papillomavirus RNA quality detection.采用 HPV-meta 进行人乳头瘤病毒 RNA 质量检测。
Sci Rep. 2022 Jul 29;12(1):13058. doi: 10.1038/s41598-022-17318-5.
6
Molecular Detection Methods in HPV-Related Cancers.人乳头瘤病毒相关癌症的分子检测方法
Front Oncol. 2022 Apr 27;12:864820. doi: 10.3389/fonc.2022.864820. eCollection 2022.
7
A comprehensive HPV-STI NGS assay for detection of 29 HPV types and 14 non-HPV sexually transmitted infections.一种用于检测29种HPV类型和14种非HPV性传播感染的综合HPV-STI二代测序检测方法。
Infect Agent Cancer. 2022 Mar 21;17(1):9. doi: 10.1186/s13027-022-00420-8.
8
2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.2019年美国阴道镜和子宫颈病理学会基于风险的子宫颈癌筛查异常检测及癌前病变管理共识指南。
J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525.
9
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.2018 年归因于感染的癌症全球负担:全球发病率分析。
Lancet Glob Health. 2020 Feb;8(2):e180-e190. doi: 10.1016/S2214-109X(19)30488-7. Epub 2019 Dec 17.
10
A review of the FDA-approved molecular testing platforms for human papillomavirus.美国食品药品监督管理局(FDA)批准的用于人乳头瘤病毒的分子检测平台综述。
J Am Soc Cytopathol. 2019 Sep-Oct;8(5):284-292. doi: 10.1016/j.jasc.2019.06.001. Epub 2019 Jun 13.